PCD Pharma Franchise Guide

The Growth Scope of Specialized Therapeutic Portfolios: Cardiac, Diabetic & Derm in 2026

Published Date · 05 September 2026

Why specialised portfolios matter

A specialised therapeutic portfolio can help a PCD franchise move from a broad catalogue to a focused territory strategy. Cardiac, diabetic and dermatology segments can each support recurring professional relationships, but the opportunity depends on local demand, prescriber concentration, competition, product relevance and compliance.

Cardiac portfolio strategy

Cardiology-focused products can be mapped to territories with relevant specialists, physicians, hospitals and chronic-care practices. The commercial priority should be accurate product information, dependable availability and repeat fulfilment rather than simply carrying a large number of SKUs.

Looking for empty territories? Mensa Medicare offers 100% exclusive monopoly rights.

Enquire Now on WhatsApp

Diabetic portfolio strategy

Diabetes management creates recurring-care requirements, making continuity of supply commercially important. A portfolio can include relevant products and supportive categories where legally and commercially appropriate.

Selection must follow approved indications, current regulations and professional medical judgement. A recurring market does not justify unsupported product claims.

Dermatology portfolio strategy

Dermatology can support focused portfolios around topical and other relevant formulations. Packaging consistency, product availability and pharmacy coverage can be particularly important in local markets.

Build the range around actual prescriber demand instead of adding every possible dermatology SKU.

Choose the segment with a territory scorecard

Score cardiac, diabetic and dermatology opportunities by prescriber density, pharmacy network, competition, expected order frequency, product availability, inventory risk and field capability.

A city with strong specialist-clinic concentration may justify a focused strategy, while another market may support a mixed chronic-care portfolio.

Build a data-driven 2026 launch

Month one: map the territory and select the core basket. Month two: establish professional and pharmacy coverage. Month three: analyse repeat orders, stock ageing and product-level contribution.

Mensa Medicare's supplied homepage describes a portfolio including cardiology and dermatology and more than 150 formulations. Current product availability and commercial terms should be verified before planning a launch.